Proteomic Signature for Detection of High Grade Ovarian Cancer in germline BRCA mutation carriers. Bahar-Shany K, Barnabas GD, Deutsch L, Deutsch N, et al. Int J Cancer 2022 Oct 10. doi: 10.1002/ijc.34318.

Read + Share

Amedeo Smart

Independent Medical Education

Bahar-Shany K, Barnabas GD, Deutsch L, Deutsch N, et al. Proteomic Signature for Detection of High Grade Ovarian Cancer in germline BRCA mutation carriers. Int J Cancer 2022 Oct 10. doi: 10.1002/ijc.34318.
PMID: 36214786